GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Forward Dividend Yield %

GlaxoSmithKline Pharmaceuticals (BOM:500660) Forward Dividend Yield % : 1.53% (As of May. 05, 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Forward Dividend Yield %?

As of today (2024-05-05), the Forward Annual Dividend Yield of GlaxoSmithKline Pharmaceuticals is 1.53%.

As of today (2024-05-05), the Trailing Annual Dividend Yield of GlaxoSmithKline Pharmaceuticals is 1.53%.

BOM:500660's Forward Dividend Yield % is ranked worse than
56.85% of 496 companies
in the Drug Manufacturers industry
Industry Median: 1.82 vs BOM:500660: 1.53

GlaxoSmithKline Pharmaceuticals's Dividends per Share for the three months ended in Dec. 2023 was ₹0.00.

During the past 12 months, GlaxoSmithKline Pharmaceuticals's average Dividends Per Share Growth Rate was 6.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 14.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 15.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Pharmaceuticals was 45.80% per year. The lowest was -17.60% per year. And the median was 11.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield % falls into.



GlaxoSmithKline Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

GlaxoSmithKline Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 32.0000002023-06-302023-06-302023-07-28Cash DividendannuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

GlaxoSmithKline Pharmaceuticals's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=32/2093.85
=1.53 %

Current Share Price is ₹2093.85.
GlaxoSmithKline Pharmaceuticals's Dividends per Share for the forward twelve months is calculated as ₹32 * 1 = ₹32.

GlaxoSmithKline Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=32/2093.85
=1.53 %

Current Share Price is ₹2093.85.
GlaxoSmithKline Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals  (BOM:500660) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


GlaxoSmithKline Pharmaceuticals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines